Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial.

Saved in:
Bibliographic Details
Title: Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial.
Authors: Nutman, Amir1,2,3,4 (AUTHOR) anutman@gmail.com, Temkin, Elizabeth1 (AUTHOR), Lellouche, Jonathan1,5 (AUTHOR), Amar Ben Dalak, Maayan1 (AUTHOR), Kaplan, Ella1 (AUTHOR), Lurie-Weinberger, Mor1 (AUTHOR), Dishon Benattar, Yael6,7,8 (AUTHOR), Neuberger, Ami6,8,9 (AUTHOR), Stern, Anat6,8,9 (AUTHOR), Daitch, Vered2,10,11 (AUTHOR), Eliakim-Raz, Noa2,10,11 (AUTHOR), Durante-Mangoni, Emanuele12,13,14 (AUTHOR), Bernardo, Mariano12,13,14 (AUTHOR), Iossa, Domenico12,13,14 (AUTHOR), Daikos, George15,16 (AUTHOR), Skiada, Anna15,16 (AUTHOR), Pavleas, Ioannis16,17 (AUTHOR), Friberg, Lena18,19 (AUTHOR), Theuretzbacher, Ursula20 (AUTHOR), Leibovici, Leonard2,11,21 (AUTHOR)
Source: Antimicrobial Resistance & Infection Control. 11/5/2025, Vol. 14 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20472994
DOI:10.1186/s13756-025-01651-1